Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Dark microglia: A new phenotype predominantly associated with pathological states.
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis (Abili-T)
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
Alemtuzumab: The advantages and challenges of a novel therapy in MS.
Fingolimod Increases CD39-Expressing Regulatory T Cells in Multiple Sclerosis Patients.
Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation.
A case of septal panniculitis secondary to interferon treatment.
Peroxisome proliferator-activated receptor (PPAR)α and -γ regulate IFNγ and IL-17A production by human T cells in a sex-specific way.
Cannabinoids control spasticity and tremor in a multiple sclerosis model.
Treatment of the chronic progressive form of multiple sclerosis with a combination of cyclophosphamide and prednisone.
Pediatric Acute Transverse Myelitis Overview and Differential Diagnosis.
Hypothermia, Hypotension, Hypersomnia, and Obesity Associated With Hypothalamic Lesions in a Patient Positive for the Anti-aquaporin 4 Antibody: A Case Report and Literature Review.
Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity.
Enhanced In Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis.
MIS416, a non-toxic microparticle adjuvant derived from Propionibacterium acnes comprising immunostimulatory muramyl dipeptide and bacterial DNA promotes cross-priming and Th1 immunity.
Alemtuzumab Therapy for Multiple Sclerosis.
Value of susceptibility-weighted imaging in acute hemorrhagic leukoencephalitis.
Natalizumab in spinal multiple sclerosis in a daily clinical setting.
Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants.
A Phase 2, Multicenter, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis.
Lipid microarrays identify key mediators of autoimmune brain inflammation.
Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
Home-based exercise program and fall-risk reduction in older adults with multiple sclerosis: phase 1 randomized controlled trial.
Neuromodulation of lower limb motor control in restorative neurology.

Pages